Company: LBRX
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001193125-25-268174
Chunk: 8

Company: LB PHARMACEUTICALS INC
Filing Date: 2025-11-06
Form: 10-Q
Item: Item 6
Chunk 8
---
.12 
     August 22, 2025 

     10.6
      
     Amended and Restated Executive Employment Agreement, dated September 4, 2025, between Anna Eramo and the Registrant
     S-1/A 
     333-289812 
     10.15 
     September 8, 2025 

     10.7
      
     Amended and Restated Executive Employment Agreement, dated September 3, 2025, between Marc Panoff and the Registrant
     S-1/A
     333-289812 
     10.16 
     September 8, 2025 

     10.8
      
     Non-Employee Director Compensation Policy
     S-1/A
     333-289812
     10.23
     September 8, 2025

     31.1+*
      
     Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

     31.2+*
      
     Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

     32.1+*
      
     Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

     101.INS
      
     Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.

     101.SCH
      
     Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents

     104
      
     Cover Page Interactive Data File (embedded within the Inline XBRL document)

+  Filed herewith.

* These certifications are being furnished solely to accompany this quarterly report pursuant to 18 U.S.C. Section 1350, and are not being filed for purposes of Section 18 of the Securities Exchange Act of 1934 and